Zlatkovskaia N M, Kleĭmenova I S, Evdoshenko V G, Zelenaia S N, Fuger N M
Antibiotiki. 1975 Apr;20(4):365-9.
Prodigiozan was tested in complex therapy of children with acute dysentery. Comparison of clinical symptoms, specific immunogenesis and child sanation periods from Shigella in the child groups treated (80) and non-treated (74) with prodigiozan showed that prodigiozan lowered the rate of intrahospital acute respiratory virus infection, provided more favourable dysentery progression, more tensed specific immunity and the patient clearance from Shigella.
对儿童急性痢疾采用复合疗法时对灵菌红素进行了测试。在接受(80例)和未接受(74例)灵菌红素治疗的儿童组中,比较临床症状、特异性免疫发生情况以及儿童志贺菌清除期,结果显示灵菌红素降低了院内急性呼吸道病毒感染率,使痢疾病情进展更为有利,增强了特异性免疫力,并促进了患者体内志贺菌的清除。